pd 153035 has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of chronic liver disease." | 1.51 | Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice. ( Choung, S; Joung, KH; Kim, HJ; Kim, JM; Ku, BJ; Lee, ES, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choung, S | 1 |
| Kim, JM | 1 |
| Joung, KH | 1 |
| Lee, ES | 1 |
| Kim, HJ | 1 |
| Ku, BJ | 1 |
1 other study available for pd 153035 and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice.
Topics: Animals; Cell Line, Tumor; Diabetes Mellitus, Experimental; Dietary Fats; ErbB Receptors; Humans; Li | 2019 |